Issued Patents All Time
Showing 1–12 of 12 patents
| Patent # | Title | Co-Inventors | Date |
|---|---|---|---|
| 12280054 | Treatment of hidradenitis suppurativa using JAK inhibitors | Michael Howell | 2025-04-22 |
| 12268667 | JAK1 pathway inhibitors for the treatment of prurigo nodularis | Kurt Andrew Brown | 2025-04-08 |
| 12150943 | JAK1 pathway inhibitors for the treatment of gastrointestinal disease | Krishnaswamy Yeleswaram, Gregory F. Hollis | 2024-11-26 |
| 12005067 | JAK inhibitor with a vitamin D analog for treatment of skin diseases | Zheng ZHANG, Melissa Parker, James FIDGE | 2024-06-11 |
| 11992490 | Use of JAK1 inhibitors for the treatment of cutaneous lupus erythematosus and Lichen planus (LP) | Jörg Wenzel | 2024-05-28 |
| 11957661 | JAK1 pathway inhibitors for the treatment of vitiligo | Kurt Andrew Brown, Michael Howell, Fiona Kuo, James Lee, Leandro Luiz Dos Santos +1 more | 2024-04-16 |
| 11918581 | Combination therapy comprising JAK pathway inhibitor and rock inhibitor | Michael Peel | 2024-03-05 |
| 11596632 | JAK1 pathway inhibitors for the treatment of gastrointestinal disease | Krishnaswamy Yeleswaram, Gregory F. Hollis | 2023-03-07 |
| 11466324 | Lipocalin 2 as a biomarker for IL-17 inhibitor therapy efficacy | Adam Samuel Platt, Stephen Edward Rapecki, Mara Fortunato, David Robert Rainey, Jon Leigh Rundle +1 more | 2022-10-11 |
| 11304949 | Treatment of hidradenitis suppurativa using JAK inhibitors | Michael Howell | 2022-04-19 |
| 10537566 | Combinations comprising siponimod and laquinimod for the treatment of multiple sclerosis | — | 2020-01-21 |
| 10208349 | Lipocalin 2 as a biomarker for IL-17 inhibitor therapy efficacy | Adam Samuel Platt, Stephen Edward Rapecki, Mara Fortunato, David Robert Rainey, Jon Leigh Rundle +1 more | 2019-02-19 |